PCSK9 and coronary artery disorder: For example, as mentioned before, carriers of the risk allele in the GUCY1A1 gene attain greater benefit from aspirin treatment [5], and people with high CAD polygenic risk scores profit more from treatment with statins [96,97] and PCSK9 inhibitors [98,99].